Sanofi-Aventis takes on debt of $7 billion to help pay for Genzyme buy
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has completed a debt offering of $7 billion, the proceeds of which will be used in part to fund its $20.1 billion acquisition of Genzyme.